Spring, TX, United States of America

Harry C Ledebur, Jr

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry C Ledebur, Jr. Retrieved from https://idiyas.com/inventor/harry-c-ledebur-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harry C Ledebur, Jr.

Introduction

Harry C Ledebur, Jr. is an accomplished inventor based in Spring, TX (US). He has made significant contributions to the field of gene therapy through his innovative work on steroid hormone receptors. His research focuses on developing mutated proteins that can be utilized as gene medicines.

Latest Patents

Ledebur holds a patent for a plasmid encoding a modified steroid hormone. This invention provides mutated proteins of steroid hormone receptors, which are useful for regulating gene expression in gene therapy. The patent highlights the potential of these mutated proteins in advancing medical treatments.

Career Highlights

Throughout his career, Ledebur has demonstrated a commitment to scientific advancement. His work has paved the way for new approaches in gene therapy, showcasing his expertise in the field of molecular biology.

Collaborations

Ledebur has collaborated with notable scientists such as Bert W O'Malley and Ming-Jer Tsai. These partnerships have contributed to the development of innovative solutions in gene therapy.

Conclusion

Harry C Ledebur, Jr. is a prominent figure in the field of gene therapy, with a focus on steroid hormone receptors. His contributions through patents and collaborations continue to influence advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…